Julie Rubinstein's most recent trade in Adaptive Biotechnologies Corp was a trade of 175,000 Common Stock done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Julie Rubinstein | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 175,000 | 647,754 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,044 | 607,710 (0%) | 0% | 7.0 | 279,507 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 19,461 | 588,249 (0%) | 0% | 7.0 | 136,032 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 175,000 | 511,824 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 25,580 | 486,244 (0%) | 0% | 3.4 | 87,739 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 3.56 per share. | 04 Mar 2024 | 13,490 | 472,754 (0%) | 0% | 3.6 | 48,024 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 132,979 | 359,492 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 22,668 | 336,824 (0%) | 0% | 8.6 | 194,265 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 463,344 | 463,344 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 185,338 | 231,126 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 4,613 | 226,513 (0%) | 0% | 12.0 | 55,402 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 114,469 | 114,469 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 45,788 | 45,788 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 15,000 | 225,325 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 01 Mar 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 58.64 per share. | 01 Mar 2021 | 9,471 | 845 (0%) | 0% | 58.6 | 555,379 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 57.54 per share. | 01 Mar 2021 | 4,684 | 10,316 (0%) | 0% | 57.5 | 269,517 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 58.99 per share. | 01 Mar 2021 | 845 | 0 (0%) | 0% | 59.0 | 49,847 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 15,000 | 240,325 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 56.23 per share. | 26 Feb 2021 | 15,000 | 0 (0%) | 0% | 56.2 | 843,450 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 26 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 24 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 15,000 | 270,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 14,675 | 255,325 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 24 Feb 2021 | 14,675 | 14,675 (0%) | 0% | 6.5 | 96,121 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 56.13 per share. | 24 Feb 2021 | 14,076 | 599 (0%) | 0% | 56.1 | 790,086 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 56.45 per share. | 24 Feb 2021 | 4,234 | 10,766 (0%) | 0% | 56.4 | 239,009 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 57.12 per share. | 24 Feb 2021 | 4,134 | 6,632 (0%) | 0% | 57.1 | 236,134 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 58.74 per share. | 24 Feb 2021 | 3,374 | 3,258 (0%) | 0% | 58.7 | 198,189 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 59.33 per share. | 24 Feb 2021 | 3,258 | 0 (0%) | 0% | 59.3 | 193,297 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 57.33 per share. | 24 Feb 2021 | 599 | 0 (0%) | 0% | 57.3 | 34,341 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 22 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 22 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 15,000 | 270,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 15,000 | 255,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 59.28 per share. | 22 Feb 2021 | 9,844 | 5,156 (0%) | 0% | 59.3 | 583,552 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 56.04 per share. | 22 Feb 2021 | 7,039 | 0 (0%) | 0% | 56.0 | 394,466 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 55.54 per share. | 22 Feb 2021 | 4,461 | 7,039 (0%) | 0% | 55.5 | 247,764 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 60.21 per share. | 22 Feb 2021 | 4,100 | 1,056 (0%) | 0% | 60.2 | 246,861 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 54.16 per share. | 22 Feb 2021 | 3,500 | 11,500 (0%) | 0% | 54.2 | 189,560 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 62.20 per share. | 22 Feb 2021 | 656 | 0 (0%) | 0% | 62.2 | 40,803 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 61.01 per share. | 22 Feb 2021 | 400 | 656 (0%) | 0% | 61.0 | 24,404 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 15,000 | 285,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 19 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 62.30 per share. | 19 Feb 2021 | 7,708 | 3,793 (0%) | 0% | 62.3 | 480,208 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 63.03 per share. | 19 Feb 2021 | 3,793 | 0 (0%) | 0% | 63.0 | 239,073 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 61.47 per share. | 19 Feb 2021 | 3,499 | 11,501 (0%) | 0% | 61.5 | 215,084 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 15,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 15,000 | 315,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 62.28 per share. | 17 Feb 2021 | 9,799 | 0 (0%) | 0% | 62.3 | 610,282 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 61.20 per share. | 17 Feb 2021 | 9,108 | 0 (0%) | 0% | 61.2 | 557,410 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 60.49 per share. | 17 Feb 2021 | 5,892 | 9,108 (0%) | 0% | 60.5 | 356,407 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 61.63 per share. | 17 Feb 2021 | 5,201 | 9,799 (0%) | 0% | 61.6 | 320,538 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 15,000 | 330,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 15,000 | 345,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 12 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 12 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 65.31 per share. | 12 Feb 2021 | 13,301 | 0 (0%) | 0% | 65.3 | 868,688 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 66.38 per share. | 12 Feb 2021 | 9,621 | 300 (0%) | 0% | 66.4 | 638,642 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 65.55 per share. | 12 Feb 2021 | 3,130 | 9,921 (0%) | 0% | 65.6 | 205,172 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 64.53 per share. | 12 Feb 2021 | 1,949 | 13,050 (0%) | 0% | 64.5 | 125,769 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 64.78 per share. | 12 Feb 2021 | 1,699 | 13,301 (0%) | 0% | 64.8 | 110,061 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 67.00 per share. | 12 Feb 2021 | 300 | 0 (0%) | 0% | 67 | 20,100 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 10 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 15,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 15,000 | 375,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 10 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 63.12 per share. | 10 Feb 2021 | 10,729 | 4,271 (0%) | 0% | 63.1 | 677,214 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 62.14 per share. | 10 Feb 2021 | 6,770 | 8,230 (0%) | 0% | 62.1 | 420,688 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 63.67 per share. | 10 Feb 2021 | 4,271 | 0 (0%) | 0% | 63.7 | 271,935 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 63.00 per share. | 10 Feb 2021 | 3,814 | 4,416 (0%) | 0% | 63 | 240,282 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 64.09 per share. | 10 Feb 2021 | 3,798 | 618 (0%) | 0% | 64.1 | 243,414 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 64.76 per share. | 10 Feb 2021 | 618 | 0 (0%) | 0% | 64.8 | 40,022 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 15,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 08 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.3 | 94,800 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 61.96 per share. | 08 Feb 2021 | 10,656 | 4,344 (0%) | 0% | 62.0 | 660,246 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 10,000 | 390,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 08 Feb 2021 | 10,000 | 10,000 (0%) | 0% | 6.6 | 65,500 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 61.81 per share. | 08 Feb 2021 | 7,611 | 7,389 (0%) | 0% | 61.8 | 470,436 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 63.02 per share. | 08 Feb 2021 | 7,389 | 0 (0%) | 0% | 63.0 | 465,655 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 08 Feb 2021 | 5,000 | 15,000 (0%) | 0% | 6.3 | 31,600 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 62.43 per share. | 08 Feb 2021 | 4,344 | 0 (0%) | 0% | 62.4 | 271,196 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 05 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.3 | 94,800 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 15,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 05 Feb 2021 | 9,850 | 0 (0%) | 0% | 60.1 | 592,182 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 59.64 per share. | 05 Feb 2021 | 5,150 | 9,850 (0%) | 0% | 59.6 | 307,146 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 03 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.3 | 94,800 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 03 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.3 | 94,800 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 15,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 15,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 59.39 per share. | 03 Feb 2021 | 8,655 | 6,345 (0%) | 0% | 59.4 | 514,020 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 58.77 per share. | 03 Feb 2021 | 8,305 | 6,695 (0%) | 0% | 58.8 | 488,085 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 59.25 per share. | 03 Feb 2021 | 6,695 | 0 (0%) | 0% | 59.3 | 396,679 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 60.16 per share. | 03 Feb 2021 | 5,435 | 910 (0%) | 0% | 60.2 | 326,970 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 60.82 per share. | 03 Feb 2021 | 910 | 0 (0%) | 0% | 60.8 | 55,346 | Common Stock |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 15,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 15,000 | 80,000 | - | - | Stock Option (Right to Buy) |